Is Curis, Inc. (CRIS) a Buy, Sell, or Hold?
NASDAQ : CRIS
Curis, Inc. — Institutional Ownership
$4.02 USD
-$0.39 (-8.84%)
- Volume
- 69.17K
- Average Volume
- 166.83K
- Market Capitalization
- $7.83M
- P/E Ratio
- -0.17
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $39.00
- Year Low
- $3.60
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.00
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Armistice Capital, LLC | 679.03K | 4.99% |
| 2026-05-14 | Thomas A. Satterfield, Jr. | 3.96M | 9.90% |
| 2026-04-24 | Nantahala Capital Management, LLC | 4.22M | 9.99% |
| 2026-04-07 | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 2.94M | 6.98% |
| 2026-04-07 | Nantahala Capital Management, LLC | 4.22M | 9.99% |
| 2026-03-27 | Stonepine Capital Management, LLC | 4.03M | 9.90% |
| 2026-02-17 | Armistice Capital, LLC | 1.34M | 9.99% |
| 2026-01-23 | M28 Capital Management LP | 620.17K | 4.80% |
| 2025-11-14 | Maverick Capital, Ltd. | 49554.0 | 0.40% |
| 2025-08-14 | Armistice Capital, LLC | 1.29M | 9.99% |
| 2025-08-13 | M28 Capital Management LP | 620.17K | 5.90% |
| 2025-05-15 | Armistice Capital, LLC | 1.05M | 9.99% |
| 2025-04-16 | Thomas A. Satterfield, Jr. | 1.04M | 9.90% |
| 2025-03-31 | Bleichroeder LP | 1.04M | 9.90% |
| 2025-02-14 | Maverick Capital, Ltd. | 681.38K | 8.00% |
| 2025-02-12 | Thomas A. Satterfield, Jr. | 790.43K | 9.10% |
| 2024-04-15 | M. Kingdon Offshore Master Fund L.P. | 311.16K | 5.30% |
| 2024-04-15 | Kingdon Capital Management, L.L.C. | 345.73K | 5.90% |
| 2024-04-15 | Mark Kingdon | 345.73K | 5.90% |
| 2024-04-15 | Kingdon GP, LLC | 311.16K | 5.30% |
| 2024-02-12 | Marc Elia | 421.95K | 7.20% |
| 2024-02-12 | M28 Capital Management LP | 421.95K | 7.20% |
| 2022-07-08 | (1) BlackRock, Inc. | 2.36M | 2.60% |
| 2022-02-14 | 75-2482446 | 7.79M | 8.50% |
| 2022-02-14 | 75-2686461 | 7.79M | 8.50% |
| 2022-02-14 | III | 7.79M | 8.50% |
| 2022-02-11 | STATE STREET CORPORATION | 7.8M | 8.51% |
| 2022-02-11 | SSGA FUNDS MANAGEMENT, INC. | 6.34M | 6.92% |
| 2022-02-10 | Adage Capital Partners GP, L.L.C. | 200K | 0.22% |
| 2022-02-10 | Adage Capital Advisors, L.L.C. | 200K | 0.22% |
| 2022-02-10 | Robert Atchinson | 200K | 0.22% |
| 2022-02-10 | Phillip Gross | 200K | 0.22% |
| 2022-02-10 | Sio Capital Management, LLC 20-4586565 | 3.87M | 4.22% |
| 2022-02-10 | Adage Capital Partners, L.P. | 200K | 0.22% |
| 2022-02-04 | (1) BlackRock, Inc. | 6.28M | 6.90% |
| 2021-11-15 | 2 | 10.0 | 0.00% |
| 2021-11-15 | 2 | - | 0.00% |
| 2021-11-15 | 2 | - | 0.00% |
| 2021-11-15 | 2 | - | 0.00% |
| 2021-03-22 | Steven A. Cohen | 5.34M | 4.00% |
| 2021-03-22 | Point72 Asset Management, L.P. | 5.34M | 4.00% |
| 2021-03-22 | Cubist Systematic Strategies, LLC | 400.0 | 4.00% |
| 2021-03-22 | Point72 Capital Advisors, Inc. | 5.34M | 4.00% |
| 2021-02-16 | Rajeev Shah | 7.71M | 8.50% |
| 2021-02-16 | Sio Capital Management, LLC 20-4586565 | 4.76M | 5.78% |
| 2021-02-11 | BVF GP HOLDINGS LLC | 575.48K | 1.00% |
| 2021-02-11 | Mark N. Lampert | 626.94K | 1.00% |
| 2021-02-11 | Biotechnology Value Trading Fund OS LP | 40044.0 | 1.00% |
| 2021-02-11 | Biotechnology Value Fund, L.P. | 331.47K | 1.00% |
| 2021-02-11 | Biotechnology Value Fund II, L.P. | 244.01K | 1.00% |
| 2021-02-11 | BVF I GP LLC | 331.47K | 1.00% |
| 2021-02-11 | BVF Inc. | 626.94K | 1.00% |
| 2021-02-11 | BVF Partners OS Ltd. | 40044.0 | 1.00% |
| 2021-02-11 | BVF II GP LLC | 244.01K | 1.00% |
| 2021-02-11 | BVF Partners L.P. | 626.94K | 1.00% |
| 2021-02-01 | Adage Capital Partners, L.P. | 5M | 5.49% |
| 2021-02-01 | Robert Atchinson | 5M | 5.49% |
| 2021-02-01 | Phillip Gross | 5M | 5.49% |
| 2021-02-01 | Adage Capital Partners GP, L.L.C. | 5M | 5.49% |
| 2021-02-01 | Adage Capital Advisors, L.L.C. | 5M | 5.49% |
| 2020-06-22 | Biotechnology Value Trading Fund OS LP | 247.81K | 1.00% |
| 2020-06-22 | BVF I GP LLC | 1.91M | 3.80% |
| 2020-06-22 | Biotechnology Value Fund II, L.P. | 1.42M | 2.80% |
| 2020-06-22 | BVF II GP LLC | 1.42M | 2.80% |
| 2020-06-22 | Biotechnology Value Fund, L.P. | 1.91M | 3.80% |
| 2020-06-22 | BVF Partners OS Ltd. | 247.81K | 1.00% |
| 2020-06-22 | BVF GP HOLDINGS LLC | 3.33M | 6.60% |
| 2020-06-22 | BVF Partners L.P. | 3.65M | 7.20% |
| 2020-06-22 | BVF Inc. | 3.65M | 7.20% |
| 2020-06-22 | Mark N. Lampert | 3.65M | 7.20% |
| 2019-01-09 | Tax ID # 57-1156902 | 448.55K | 1.35% |
| 2018-07-10 | (1) BlackRock, Inc. | 805.08K | 2.40% |
| 2018-02-07 | Tax ID # 57-1156902 | 24.9M | 15.18% |
| 2018-01-29 | (1) BlackRock, Inc. | 9.72M | 5.90% |
| 2018-01-10 | FMR LLC | 7.21M | 4.39% |
| 2018-01-10 | Abigail P. Johnson | 7.21M | 4.39% |
| 2017-01-23 | (1) BlackRock, Inc. | 9.22M | 6.60% |
| 2016-09-13 | 2 | 27.33M | 19.60% |
| 2016-09-13 | 2 | 27.33M | 19.60% |
| 2016-09-13 | 2 | 27.33M | 19.60% |
| 2016-02-01 | Tax ID # 57-1156902 | 24.01M | 18.70% |
| 2016-01-28 | (1) BlackRock, Inc. | 8.04M | 6.30% |
| 2015-03-10 | FMR LLC | 16.63M | 13.31% |
| 2015-03-10 | Select Health Care Portfolio | 6.82M | 5.46% |
| 2015-03-10 | Edward C. Johnson 3d | 16.63M | 13.31% |
| 2015-03-10 | Abigail P. Johnson | 16.63M | 13.31% |
| 2015-03-09 | Tax ID # 57-1156902 | 24.01M | 18.72% |
| 2015-01-29 | Tax ID # 57-1156902 | 20.62M | 23.90% |
| 2015-01-28 | 2 | 17.12M | 16.60% |
| 2015-01-28 | 2 | 17.12M | 16.60% |
| 2015-01-28 | 2 | 17.12M | 16.60% |
| 2014-02-14 | Tax ID # 57-1156902 | 18.13M | 21.08% |
| 2014-01-28 | (1) BlackRock, Inc. | 6.68M | 7.80% |
| 2013-06-14 | Tax ID # 57-1156902 | 17.09M | 21.31% |
| 2013-02-12 | Battery Ventures VIII, L.P. (“BV8”) | 6.87M | 13.70% |
| 2013-02-11 | Tax ID # 57-1156902 | 16.92M | 21.10% |
| 2013-02-06 | (1) BlackRock, Inc. | 5.33M | 6.66% |
| 2012-02-13 | (1) BlackRock, Inc. | 4.72M | 6.17% |
| 2012-01-30 | Tax ID # 57-1156902 | 17.5M | 22.77% |
| 2012-01-30 | Tax ID # 57-1156902 | 17.36M | 22.60% |
| 2011-03-16 | Tax ID # 57-1156902 | 17.63M | 23.23% |
| 2011-02-15 | Tax ID # 57-1156902 | 17.69M | 22.84% |
| 2011-02-10 | Tax ID # 57-1156902 | 16.61M | 22.84% |
| 2011-02-04 | (1) BlackRock, Inc. | 4.26M | 5.64% |
| 2010-02-12 | OrbiMed Advisors LLC | 435.4K | 11.00% |
| 2010-02-12 | Samuel D. Isaly | 3.83M | 11.00% |
| 2010-02-12 | OrbiMed Capital LLC | 3.4M | 11.00% |
| 2009-08-07 | Tax ID # 57-1156902 | 12.43M | 18.70% |
| 2009-05-05 | Tax ID # 57-1156902 | 10.25M | 16.10% |
| 2009-02-12 | Tax ID # 57-1156902 | 6.77M | 10.66% |
| 2008-12-05 | Tax ID # 57-1156902 | 6.41M | 10.11% |
| 2008-02-13 | W. BRADFORD STEPHENS | 3.98M | 6.30% |
| 2008-02-13 | PAUL H. STEPHENS | 4.28M | 6.80% |
| 2008-02-13 | W. BRADFORD STEPHENS | 3.98M | 6.30% |
| 2008-02-13 | STEPHENS INVESTMENT MANAGEMENT, LLC | 3.98M | 6.30% |
| 2008-02-13 | PAUL H. STEPHENS | 4.28M | 6.80% |
| 2008-02-13 | P. BARTLETT STEPHENS | 3.98M | 6.30% |
| 2008-02-13 | P. BARTLETT STEPHENS | 3.98M | 6.30% |
| 2008-02-13 | STEPHENS INVESTMENT MANAGEMENT, LLC | 3.98M | 6.30% |
| 2008-02-13 | PAUL H. STEPHENS | 4.28M | 6.80% |
| 2008-02-13 | STEPHENS INVESTMENT MANAGEMENT, LLC | 3.98M | 6.30% |
| 2008-02-13 | W. BRADFORD STEPHENS | 3.98M | 6.30% |
| 2008-02-13 | STEPHENS INVESTMENT MANAGEMENT, LLC | 3.98M | 6.30% |
| 2008-02-13 | W. BRADFORD STEPHENS | 3.98M | 6.30% |
| 2008-02-13 | P. BARTLETT STEPHENS | 3.98M | 6.30% |
| 2008-02-13 | PAUL H. STEPHENS | 4.28M | 6.80% |
| 2008-02-13 | P. BARTLETT STEPHENS | 3.98M | 6.30% |
| 2008-02-01 | Investment 10, L.L.C. | 399.38K | 0.60% |
| 2008-02-01 | Biotechnology Value Fund II, L.P. | 939.68K | 1.50% |
| 2008-02-01 | BVF Partners L.P. | 6.17M | 9.70% |
| 2008-02-01 | BVF Inc. | 6.17M | 9.70% |
| 2008-02-01 | BVF Investments, L.L.C. | 3.46M | 5.40% |
| 2008-02-01 | Biotechnology Value Fund, L.P. | 1.38M | 2.20% |
| 2007-08-15 | Richard H. Aldrich | 7.52M | 11.90% |
| 2007-08-15 | RA Capital Biotech Fund, L.P. | 7.39M | 11.70% |
| 2007-08-15 | Peter Kolchinsky | 7.52M | 11.90% |
| 2007-08-15 | RA Capital Biotech Fund II, L.P. | 132.36K | 0.00% |
| 2007-08-15 | Capital Management, LLC | 7.52M | 11.90% |
| 2004-03-23 | Paul G. Allen | 918.66K | 2.20% |
| 2004-03-23 | Vulcan Ventures Incorporated | 918.66K | 2.20% |
CRIS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $19.74 | 658.2K | $12.99M | $5.06M | $1.62M | $9.55M |
| 2024-12-31 | $61.20 | 315.31K | $19.3M | $20M | $2.95M | $2.25M |
| 2023-12-31 | $255.00 | 264.66K | $67.49M | $26.68M | $2.79M | $43.6M |
| 2022-12-31 | $220.00 | 233.48K | $51.37M | $19.66M | $3.94M | $35.65M |
| 2021-12-31 | $1904.00 | 228.92K | $435.87M | $40.01M | $5.04M | $400.89M |
| 2020-12-31 | $3276.00 | 121.68K | $398.61M | $129.61M | $7.66M | $276.66M |
| 2019-12-31 | $680.00 | 82951 | $56.41M | $15.43M | $166K | $41.14M |
| 2018-12-31 | $276.00 | 82795 | $22.85M | $23.64M | $35.48M | $34.7M |
| 2017-12-31 | $1400.00 | 14913 | $20.88M | $38.29M | $41.56M | $24.15M |
| 2016-12-31 | $6160.00 | 66392 | $408.97M | $26.04M | $19.86M | $402.8M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10.95 | 968.17K | $10.6M | $15M | $1.34M | -$3.06M |
| 2025-12-31 | $19.74 | 787.35K | $15.54M | $5.06M | $1.62M | $12.1M |
| 2025-09-30 | $33.20 | 784.01K | $26.03M | $9.05M | $1.97M | $18.95M |
| 2025-06-30 | $46.40 | 631.38K | $29.3M | $10.14M | $2.31M | $21.47M |
| 2025-03-31 | $42.00 | 424.69K | $17.84M | $20.28M | $2.64M | $194.15K |
| 2024-12-31 | $61.20 | 383.56K | $23.47M | $20M | $2.95M | $6.43M |
| 2024-09-30 | $107.80 | 297.05K | $32.02M | $20.85M | $3.26M | $14.43M |
| 2024-06-30 | $127.60 | 290.92K | $37.12M | $10M | $3.56M | $30.68M |
| 2024-03-31 | $253.60 | 289.18K | $73.34M | $29.96M | $42.61M | $85.99M |
| 2023-12-31 | $255.00 | 288.61K | $73.6M | $26.68M | $2.79M | $49.71M |
| 2023-09-30 | $131.80 | 286.04K | $37.7M | $24.47M | $3.09M | $16.32M |
| 2023-06-30 | $332.00 | 241.71K | $80.25M | $19.82M | $3.38M | $63.81M |